Singapore: A novel study by Cancer Science Institute of Singapore (CSI Singapore) at National University of Singapore (N...
Singapore: RUNX3, a gene that is intensively studied for its function as a tumour suppressor, is likely to be a key and ...
Singapore: In a recent report released by KPMG and the Federation of Indian Chambers of Commerce and Industry (FICCI) - ...
Singapore: According to the latest research findings by the University of Singapore, thinking about love or romance make...
Singapore: Singapore's President's Technology Award (PTA), 2014 is conferred to two teams in biomedical sector who have ...
Singapore: In a bid to further foster new drug research for drug resistant tuberculosis (TB), Wellcome Trust has collabo...
Singapore: Singapore has unvieled Fusionopolis Two, a new R&D hub for bringing public and private sector together to...
Singapore: With the average cost of getting a novel drug to market at almost $2.5 billion, and few products achieving bl...
Singapore: Panama-based iSirona, a provider of simplified solutions for medical device integration, has formed a strateg...
Singapore: J Uriach & Cia, a Barcelona-based Grupo Uriach company, and Singapore's sales and marketing company Hyphe...
Delivering pharmaceutical products to the designated market at right time and in right condition is the most critical ta...
Singapore: With the presence of major international medtech companies in the country, Singapore's key concern is to grow...
Singapore: A team of scientists from Cancer Science Institute of Singapore (CSI Singapore) at the National University of...
Singapore: Singapore Ministry of Health (MOH) has assessed that the Ebola outbreak in West Africa poses a low public hea...
Singapore: Breast cancer therapeutics pipeline has higher innovation in first-in-class molecules, with many new technolo...
Singapore: Scientists at A*Star's Genome Institute of Singapore (GIS) have discovered an unusual gene that controls the ...
Singapore: Singapore's biopharmaceutical company, MerLion Pharmaceuticals, has recieved positive results from a phase 2 ...
Singapore: AbbVie, a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott, h...
